drugset / Trial / NCT04210505

Summary

Hemodialysis patients are at high-risk for infections, specifically Staphylococcus aureus infections. The investigators propose to 1) implement a novel intervention (nasal povidone-iodine at each hemodialysis session) to prevent S. aureus infections using a stepped-wedge cluster randomized trial, and 2) evaluate the feasibility and acceptability of this intervention. If successful, this intervention can be used among hemodialysis patients, and evaluated in other high-risk patient populations to prevent S. aureus infections.

Timeline

Start
2020-09-29
Primary completion
2024-01-31
Completion
2024-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Povidone-Iodine Other / unclassified Intranasal